Thomas F. Ryan Jr., Director at REPLIGEN CORP (RGEN), sold 4,000 shares at $34.83 ($139K) on 2017-03-20, disclosed to the SEC on 2017-03-22.
Open-market sale of $139k RGEN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RGEN | SELL | 2021-08-05 | $195K | — | Filing → |
| RGEN | SELL | 2021-03-04 | $205K | — | Filing → |
| RGEN | SELL | 2020-11-13 | $351K | — | Filing → |